SCHEMBL30195183

SCHEMBL30195183

CC(C)Cc1ccc(S(=O)(=O)Nc2ncccn2)c(-c2ccc(Cn3ccnc3)c(F)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 17/20 0.52
EDNRB P24530 1/20 0.41
EDNRA P25101 1/20 0.41
PIK3CA P42336 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30194912 0.89 AGTR2 (0.64) AGTR2
SCHEMBL30195155 0.85 PIK3CA (0.40) AGTR2EDNRBEDNRAPIK3CA
SCHEMBL30195042 0.84 AGTR2 (0.40) AGTR2EDNRBEDNRA
SCHEMBL30195009 0.83 AGTR2 (0.47) AGTR2
SCHEMBL30194921 0.83 AGTR2 (0.39) AGTR2EDNRBEDNRA
SCHEMBL30194990 0.82 AGTR2 (0.65) AGTR2
SCHEMBL30195166 0.81 AGTR2 (0.43) AGTR2EDNRBEDNRA
SCHEMBL30195170 0.77 AGTR2 (0.48) AGTR2
SCHEMBL30195090 0.77 AGTR2 (0.43) AGTR2
SCHEMBL30970207 0.76 AGTR2 (0.40) AGTR2EDNRBEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367110-A1 NEW SELECTIVE ANGIOTENSIN II COMPOUNDS Vicore Pharma AB (SE) 2024-05-15 EP claimed
CN-117916229-A Novel selective angiotensin II compounds 维科尔药物公司 2024-04-19 CN claimed
WO-2023281271-A1 NEW SELECTIVE ANGIOTENSIN II COMPOUNDS VICORE PHARMA AB (SE) 2023-01-12 WO claimed
CN-117916229-A Novel selective angiotensin II compounds 维科尔药物公司 2024-04-19 CN disclosed
WO-2023281271-A1 NEW SELECTIVE ANGIOTENSIN II COMPOUNDS VICORE PHARMA AB (SE) 2023-01-12 WO disclosed